Clinical Trial Update: Impact of Emotional Disorders on Response to Immune Checkpoint Inhibitor Therapy in Liver Cancer

View source ↗

Summary

A clinical trial is studying whether emotional disorders influence response to immune checkpoint inhibitor therapy in liver cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Mood Disorders

Snippet

Sponsor: Tongji Hospital | Conditions: Liver Cancer, Emotional Disorder | Status: RECRUITING